The page is the record's research on the issuer — no analyst, no rating, no view.

SIHUAN PHARM (00460) — research page

HK · hk-cm-kg/HKEX/00460 · as of 2026-11-04

Identity and listing

SIHUAN PHARM is listed on the Main Board of the Hong Kong exchange under ticker 00460, with ISIN BMG8162K1137 and LEI 529900UD7C9N3AQO1V88. Its security type is Corporate and its jurisdiction is Bermuda (BM). Its segment is not on the record, and its sector is not on the record. The record states that the sector classification is published by the exchange on its website pages and not in the List of Securities. Its listing status is listed, not halted.

fieldvaluesource · read date
nameSIHUAN PHARMsource · 2026-11-04
exchangeMain Boardsource · 2026-11-04
ticker00460source · 2026-11-04
ISINBMG8162K1137source · 2026-11-04
LEI529900UD7C9N3AQO1V88source · 2026-11-04
security typeCorporatesource · 2026-11-04
segmentnot on the record
sectornot on the record
jurisdictionBermuda (BM)source · 2026-11-04
statuslisted, not haltedsource · 2026-11-04

The disclosure read

The record holds 78 filings in the twelve months to 2025-11-04 through 2026-11-04, across 57 filing days. The median gap between filing days is 5.0 days. The record holds 2 days from the latest filing to the record date of 2026-11-04. The median for the exchange is 9.0 days of cadence gap, 46.0 filings and 2.0 days of latency across 2472 issuers. The sector median is not on the record. The latest filing is dated 2026-11-02 and is a monthly return. Filings by type are 41 announcements, 13 monthly returns, 7 circulars, 4 AGM or EGM notices, 4 next-day disclosures, 2 dividends, 2 results, 1 annual report, 1 director change, 1 documents on display, 1 ESG report and 1 interim report.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer7852
exchange median: Main Board (2472 issuers)4692
datetypecategoryfiling
2026-11-02monthly_returnMonthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
2026-10-21announcementVOLUNTARY ANNOUNCEMENT- PHASE III CLINICAL STUDY DATA OF XUANZHU BIOPHARM'S ANAPRAZOLE SODIUM FOR REFLUX ESOPHAGITIS PRESENTED AT UEG WEEK 2026
2026-10-20announcementVOLUNTARY ANNOUNCEMENT - POLYCAPROLACTONE MICROSPHERE FACIAL FILLER FOR INJECTION AND HYALURONIC ACID SODIUM COMPOSITE SOLUTION FOR INJECTION INDEPENDENTLY DEVELOPED BY MEIYAN SPACE, A SUBSIDIARY OF SIHUAN PHARMACEUTICAL, APPROVED FOR MARKET LAUNCH IN HONG KONG
2026-10-08announcementVOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL COMPLETED A STRATEGIC INVESTMENT IN CANTON BIOLOGICS TO ENHANCE THE LAYOUT OF THE ENTIRE INDUSTRIAL CHAIN OF REGENERATIVE MEDICAL AESTHETICS
2026-10-05announcementVOLUNTARY ANNOUNCEMENT - NEW SPECIFICATIONS OF SKIN BOOSTER (BRAND NAME: DONGYAN) OF SIHUAN PHARMACEUTICAL APPROVED FOR LAUNCH BY NMPA

window 2025-11-04 to 2026-11-04 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Ernst & Young. Its location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as the register has no lifecycle type map yet. The halt flag shows listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/hk/suitability-sfc-code-of-conduct-paragraph-5-2/r1, with the chapter as of 2026-11-04.

rule acm-68000/hk/suitability-sfc-code-of-conduct-paragraph-5-2/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No issuer years are sealed. The live record began on 2026-09-12. Years 2021 through 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx (identity.exchange)
10.2
https://api.gleif.org/api/v1/lei-records/529900UD7C9N3AQO1V88 (identity.jurisdiction)
10.3
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.4
https://mcp.hk-cm-kg.ai/events/HKEX/00460 (the disclosure lines)
10.5
https://www.hkex.com.hk/eng/stat/smstat/dayquot/d261104e.htm (the halt flag)
10.6
https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042700708.pdf (the auditor)
10.7
https://mcp.hk-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://mcp.hk-cm-kg.ai/record/HKEX/00460 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"BMG8162K1137"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:49e19dad3ff52c83.